Search - tctmd.com

Displaying 1 - 20 of 35

Sort: Relevancy | Date

News Daily News

Asundexian Reduces Recurrent Stroke Without Bleeding Risk: OCEANIC-STROKE

Michael O'Riordan

November 24, 2025

News Opinion Editor's Corner AHA 2025

What’s Going to Be Hot at AHA 2025?

Michael O'Riordan

November 05, 2025

News Opinion CV Team Dispatch

May 2025 Dispatch for the CV Team

L.A. McKeown

May 20, 2025

News Industry News

Genomadix Inc. Announces Health Canada License for Rapid Genetic Test to Aid Therapy Selection for Stroke and Cardiovascular Disease Patients

January 30, 2025

Presentation TCT 2024

TCT 308: Colchicine for the Prevention of Recurrent Non-Cardioembolic Stroke: A Meta-Analysis of Randomized Controlled Trials

Presenter: Michael Sabina

October 29, 2024

News Opinion Editor's Corner TCT 2024

What’s Going to Be Big at TCT 2024?

Michael O'Riordan

October 17, 2024

News Opinion CV Team Dispatch

August 2024 Dispatch for the CV Team

L.A. McKeown

August 01, 2024

News Conference News ESOC 2023

Ticagrelor May Be an Option for Averting Brain Lesions During Carotid Stenting

Todd Neale

June 02, 2023

News Daily News

Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest

Michael O'Riordan

October 20, 2022

News Daily News

Risk of Repeat Stroke Underrecognized in Nonstenotic Carotid Lesions

L.A. McKeown

May 06, 2022

News Daily News

Recurrent Stroke Risk Lower With More Intense LDL-Lowering: Meta-analysis

Yael L. Maxwell

March 01, 2022

News Daily News

Predictors of AF May Help Guide Care After Stroke of Unknown Cause

Caitlin E. Cox

October 26, 2021

News Conference News ACC 2021

Rivaroxaban Helps Prevent More Events Than Aspirin Alone After Leg Interventions

L.A. McKeown

May 21, 2021

News Daily News

Short DAPT Bests Aspirin at Preventing Recurrent Events After Stroke, TIA

Yael L. Maxwell

April 29, 2021

News Daily News

Antiplatelets, Especially Cilostazol, Helpful in Moyamoya Arteriopathy

Michael O'Riordan

February 26, 2021

News Daily News

P2Y12 Inhibitor Monotherapy Edges Out Aspirin for Secondary Prevention

Yael L. Maxwell

May 15, 2020

News Daily News

FDA Gives Rivaroxaban Another VTE-Related Indication

Todd Neale

October 14, 2019

News Industry News

NobleStitch™ EL Receives Approval Of IDE To Conduct A Trial For Reduction Of Recurrent Ischemic Stroke

September 05, 2019

News Conference News ESC 2019

ESC 2019: Antiplatelets in Diabetes, CAD and A-fib, an ARNI in HFpEF, Staged Complete PCI, and More

Shelley Wood

August 22, 2019

News Daily News

PFO Compounds Ischemic Stroke Risk Among Patients With Pulmonary Embolism

Yael L. Maxwell

May 06, 2019

Advertisement

Asundexian Reduces Recurrent Stroke Without Bleeding Risk: OCEANIC-STROKE

What’s Going to Be Hot at AHA 2025?

May 2025 Dispatch for the CV Team

Genomadix Inc. Announces Health Canada License for Rapid Genetic Test to Aid Therapy Selection for Stroke and Cardiovascular Disease Patients

TCT 308: Colchicine for the Prevention of Recurrent Non-Cardioembolic Stroke: A Meta-Analysis of Randomized Controlled Trials

What’s Going to Be Big at TCT 2024?

August 2024 Dispatch for the CV Team

Ticagrelor May Be an Option for Averting Brain Lesions During Carotid Stenting

Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest

Risk of Repeat Stroke Underrecognized in Nonstenotic Carotid Lesions

Recurrent Stroke Risk Lower With More Intense LDL-Lowering: Meta-analysis

Predictors of AF May Help Guide Care After Stroke of Unknown Cause

Rivaroxaban Helps Prevent More Events Than Aspirin Alone After Leg Interventions

Short DAPT Bests Aspirin at Preventing Recurrent Events After Stroke, TIA

Antiplatelets, Especially Cilostazol, Helpful in Moyamoya Arteriopathy

P2Y12 Inhibitor Monotherapy Edges Out Aspirin for Secondary Prevention

FDA Gives Rivaroxaban Another VTE-Related Indication

NobleStitch™ EL Receives Approval Of IDE To Conduct A Trial For Reduction Of Recurrent Ischemic Stroke

ESC 2019: Antiplatelets in Diabetes, CAD and A-fib, an ARNI in HFpEF, Staged Complete PCI, and More

PFO Compounds Ischemic Stroke Risk Among Patients With Pulmonary Embolism

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content